Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 16, Issue 11

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

About this journalAbout

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 16, Issue 11 (2017)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 16, Issue 11 (2017)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Volume 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original research

Article

Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings

Nicola De Bortoli, Claudio Ripellino, Nazarena Cataldo & Santino Marchi

Pages: 1221-1225

Published online: 07 Sep 2017

AbstractforUnspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings | Full Text | References | PDF (443.9 KB)

342 Views
6 CrossRef citations
0Altmetric

Review

Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy

Gideon Koren

Pages: 1227-1234

Published online: 09 Aug 2017

AbstractforSafety considerations surrounding use of treatment options for nausea and vomiting in pregnancy | Full Text | References | PDF (601.5 KB)

1128 Views
10 CrossRef citations
0Altmetric

Review

Non-chemotherapy drug-induced neutropenia - an update

Emmanuel Andrès & Rachel Mourot-Cottet

Pages: 1235-1242

Published online: 17 Sep 2017

AbstractforNon-chemotherapy drug-induced neutropenia - an update | Full Text | References | PDF (654.5 KB)

1079 Views
26 CrossRef citations
0Altmetric

Review

The safety of available treatments for chronic constipation

Blanca Serrano-Falcón & Enrique Rey

Pages: 1243-1253

Published online: 04 Aug 2017

AbstractforThe safety of available treatments for chronic constipation | Full Text | References | PDF (848 KB)

620 Views
13 CrossRef citations
0Altmetric

Review

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)

Marta Pérez-De-Lis, Soledad Retamozo, Alejandra Flores-Chávez, Belchin Kostov, Roberto Perez-Alvarez, Pilar Brito-Zerón & Manuel Ramos-Casals

Pages: 1255-1271

Published online: 07 Sep 2017

AbstractforAutoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry) | Full Text | References | PDF (1.6 MB) | Supplemental

2197 Views
91 CrossRef citations
0Altmetric

Review

Safety issues associated with using medication to treat overactive bladder

George Araklitis & Linda Cardozo

Pages: 1273-1280

Published online: 10 Sep 2017

AbstractforSafety issues associated with using medication to treat overactive bladder | Full Text | References | PDF (650.4 KB)

525 Views
10 CrossRef citations
0Altmetric

Review

The auditory and vestibular toxicities induced by antiepileptic drugs

Sherifa A Hamed

Pages: 1281-1294

Published online: 29 Aug 2017

AbstractforThe auditory and vestibular toxicities induced by antiepileptic drugs | Full Text | References | PDF (1.1 MB)

1120 Views
22 CrossRef citations
0Altmetric

Drug Safety Evaluation

Article

The safety of edoxaban for treating atrial fibrillation

Matthias Hammwöhner & Andreas Goette

Pages: 1295-1303

Published online: 18 Sep 2017

AbstractforThe safety of edoxaban for treating atrial fibrillation | Full Text | References | PDF (1.1 MB)

397 Views
2 CrossRef citations
0Altmetric

Article

The safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis

Maria Talamo Guevara & Susanna A. McColley

Pages: 1305-1311

Published online: 21 Sep 2017

AbstractforThe safety of lumacaftor and ivacaftor for the treatment of cystic fibrosis | Full Text | References | PDF (610 KB)

806 Views
30 CrossRef citations
0Altmetric

Article

Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients

Kohei Kaku

Pages: 1313-1322

Published online: 29 Aug 2017

AbstractforSafety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patients | Full Text | References | PDF (961.3 KB)

413 Views
9 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Fluoroquinolones-related psychiatric adverse events: a real‑world retrospective and pharmacovigilance database analysis

JuanJuan Li et al.

Article | Published online: 31 Jul 2024

Signal of dementia with proton pump inhibitor after minimizing competition bias: an updated disproportionality analysis

Bin Wu et al.

Article | Published online: 31 Jul 2024

Post-marketing safety concern of PI3K inhibitors in the cancer therapies: an 8-year disproportionality analysis from the FDA adverse event reporting system

Lisha Wu et al.

Article | Published online: 31 Jul 2024

Open Access

A disproportionality analysis of CDK4/6 inhibitors in the FDA adverse event reporting system (FAERS)

Yuan Peng et al.

Article | Published online: 31 Jul 2024

Open Access

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.16, Iss.11, 2017)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?